Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Almac Group
Almac Group
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Integrity testing of HEPA filters: A practical approach
Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit...
Cleanroom Technology Conference UK 2024: Agenda launch
Hear from NASA, AstraZeneca and STERIS at the Cleanroom Technology Conference 2024. This year's agenda has launched and delegates will have the opportunity to converse with...
Legionella testing: Modern alternatives to the ‘gold standard’ test
The development of significantly faster, more sensitive testing protocols provide more options for detection Legionella than the complex plate culture test, but these also have...
Envair and Total Containment Solutions re-brand to become Envair Technology
Envair and TCS are now operating under one logo and name, Envair Technology
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Manufacturing
Almac Group launches new addition to temperature management service
Tempod 1000 has been created to improve clinical site temperature data management as manual methods of data capture have proved challenging due to disruptions caused by the global pandemic
Almac Discover appoints new VP of BD & Licensing
Dr Alan Lamont will report to Managing Director & President, Dr Stephen Barr
Manufacturing
Almac Group appoints Dr Sheryl Foster as Vice President of Quality
Estates & Facilities
Almac Group extends personalised cancer vaccine production facilities
The pharmaceutical CDMO will be investing in new labs and office spaces
Pharmaceutical
Galen appoints Dr Dennise Broderick as Managing Director
Manufacturing
Almac Group launches second line for high throughput GMP Peptide
Based in Edinburgh, Scotland, the facility manufactures neoantigen derived peptides for use in the production of patient specific, individualised cancer vaccines
Regulatory
Almac passes HSA inspection of Asia Pacific operation
The British CDMO has received renewal of the GMP/GDP certification of its Singapore facility from the Health Sciences Authority
Subscribe now